Pathogenesis of Diabetic Retinopathy

Diabetic retinopathy involves anatomic changes in retinal vessels and neuroglia. The pathogenetic mechanism responsible for retinopathy is imperfectly understood, but much of the mechanism is apparently reproduced by experimental diabetes in animals and by chronic elevation of blood galactose in nondiabetic animals. The evidence that retinopathy is a consequence of excessive blood sugars and their sequelae is consistent with a demonstrated inhibition of retinopathy by strict glycemic control in diabetic dogs. However, retinopathy in the dog model has shown a tendency to resist intervention by strict control. Biochemical and pathophysiological sequelae of hyperglycemia possibly critical to the development of retinopathy in humans and animal models are being studied in many laboratories. Retinopathy occurs in experimental galactosemia in the absence of the renal hypertrophy, mesangial expansion, and glomerular obliteration typical of diabetes in humans and dogs, implying that retinopathy and nephropathydiffer appreciably in pathogenesis.

[1]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.

[2]  T. Kern,et al.  Experimental Galactosemia Produces Diabetic-like Retinopathy , 1984, Diabetes.

[3]  T. Kern,et al.  Elevated blood viscosity in alloxan diabetic dogs and experimentally galactosemic dogs. , 1989, The Journal of diabetic complications.

[4]  S. Nelson,et al.  Relationship of Microvascular Disease in Diabetes to Metabolic Control , 1977, Diabetes.

[5]  T. Kern,et al.  Platelet Aggregation in Experimental Diabetes and Experimental Galactosemia , 1984, Diabetes.

[6]  Effect of Aspirin Alone and Aspirin Plus Dipyridamole in Early Diabetic Retinopathy: A Multicenter Randomized Controlled Clinical Trial , 1989, Diabetes.

[7]  T. Ishibashi,et al.  Platelet Aggregation and Coagulation in the Pathogenesis of Diabetic Retinopathy in Rats , 1981, Diabetes.

[8]  A. Sima,et al.  The BB Wistar rat: an experimental model for the study of diabetic retinopathy. , 1983, Metabolism: clinical and experimental.

[9]  T. Kern,et al.  Hyperglycemia and development of glomerular pathology: diabetes compared with galactosemia. , 1989, Kidney international.

[10]  P A D'Amore,et al.  Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.

[11]  T. Kern,et al.  Kidney Morphology in Experimental Hyperglycemia , 1987, Diabetes.

[12]  D. Cogan,et al.  Retinal vascular patterns. VI. Mural cells of the retinal capillaries. , 1963, Archives of ophthalmology.

[13]  K. Dahl-Jørgensen,et al.  The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. , 1988, Archives of ophthalmology.

[14]  C. Kilo,et al.  Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil. , 1988, Investigative ophthalmology & visual science.

[15]  Y. Akagi,et al.  Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. , 1988, Archives of ophthalmology.

[16]  F. D. de Oliveira,et al.  Pericytes in diabetic retinopathy. , 1966, The British journal of ophthalmology.

[17]  A. Garner,et al.  Degeneration of Intramural Pericytes in Diabetic Retinopathy , 1970, British medical journal.